U
CNMD icon

UBS’s CONMED CNMD Stock Holding History

UBS’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-400
Closed -$18K – 10396
2014
Q2 		$18K Buy
+400
New +$18.1K ﹤0.01% 8200
2014
Q1 		– Sell
-100
Closed -$4K – 10465
2013
Q4 		$4K Hold
100
– – ﹤0.01% 9688
2013
Q3 		$3K Buy
+100
New +$3.26K ﹤0.01% 9743

Other funds holding CNMD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

UBS's CNMD Position: Q3 2014 in Review

UBS reduced its CONMED (CNMD) stake by 82% in Q3 2014, selling an estimated $2.79M and leaving 15,947 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #4103.

UBS first reported a position in CNMD in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.81M in Q2 2014. 164 funds tracked by Wall St. Rank hold CNMD as of Q3 2014.

  • UBS held 15,947 shares of CONMED worth $588K as of Q3 2014.
  • UBS sold 70,350 CONMED shares in Q3 2014, an estimated $2.79M.
  • CONMED made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4103 holding.
  • UBS first reported a position in CONMED in Q2 2013 and has held it in 6 quarters since.
  • UBS's CONMED position peaked at $3.81M in Q2 2014.
  • 164 funds tracked by Wall St. Rank held CONMED as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.